Skip to content

A randomized, double blinded, split-face clinical study of the efficacy of using Eucerin Sun Dry Touch Sebum Control DP to reduce post inflammatory hyperpigmentation after Picosecond laser

A randomized, double blinded, split-face clinical study of the efficacy of using Eucerin Sun Dry Touch Sebum Control DP to reduce post inflammatory hyperpigmentation after Picosecond laser

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
TCTR
Registry ID
TCTR20210305004
Enrollment
60
Registered
2021-03-05
Start date
2021-03-11
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

mild to moderate acne vulgaris with mild to moderate acne scars Eucerin Sun Dry Touch Sebum Control DP, Post inflammatory hyperpigmentation, Picosecond laser, Sunscreen, Acne vulgaris

Interventions

Eucerin Sun Dry Touch Sebum Control DP ,Sunscreen without additional ingredients
Active Comparator Other,Placebo Comparator Other
Eucerin Sun Dry Touch Sebum Control DP ,Sunscreen

Sponsors

Beiersdorf Thailand
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. male/female at least 18 years of age 2. mild-moderate acne vulgaris with mild-moderate acne scars 3. Fitz patrick skin phototype 3 or 4 4. able to comply with study protocol 5. willingly inform consent

Exclusion criteria

Exclusion criteria: 1. unable to stop previous treatment (washout period; systemic treatment for acne 3 months, laser/phototherapy 1 month, topical treatment is 2 weeks). 2. having infection or other facial dermatologic conditions at treatment site. 3. Polycystic Ovary Syndrome (PCOS) 4. Pregnant or lactating women 5. allergic to study product.

Design outcomes

Primary

MeasureTime frame
Post inflammatory hyperpigmentation Wk 0 ,1, 2, 4, 6 Visia (Brown spots)

Secondary

MeasureTime frame
Acne count Wk 0 ,1, 2, 4, 6 Acne count,Porphyrin Wk 0 ,1, 2, 4, 6 Visia (Porphyrin),Patient satisfaction score Wk 1, 2, 4, 6 Patient satisfaction score (0-10),Acne scars Wk 1, 2, 4, 6 quartile grading scale (evaluated by dermatologist)

Countries

Thailand

Contacts

Public ContactPravit Asawanonda

Chulalongkorn University

fibrosis@gmail.com0818129393

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026